Con: Can biomarkers be gold standards in Alzheimer's disease?
-
Correspondence: Kenneth Rockwood kenneth.rockwood@dal.ca
Alzheimer's Research & Therapy 2010, 2:16 doi:10.1186/alzrt40
Accesses
- Last 30 days: 53 accesses
- Last 365 days: 523 accesses
- All time: 1856 accesses
Cited by
BioMed Central: 1 citation
|
Review
Larry G Brooks, David A Loewenstein Alzheimer's Research & Therapy 2010, 2:28 (29 September 2010) This article is part of a collection on Prevention trials From mild cognitive impairment through to dementia, Alzheimer’s disease is a continuous process and it is likely that multivariate models incorporating cognitive measures, functional variables and biomarker data are best suited to assess this longitudinal change.
|
